385 related articles for article (PubMed ID: 16211543)
1. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
[TBL] [Abstract][Full Text] [Related]
2. Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage.
Kramer AB; Laverman GD; van Goor H; Navis G
J Pathol; 2003 Sep; 201(1):160-7. PubMed ID: 12950029
[TBL] [Abstract][Full Text] [Related]
3. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis.
Kramer AB; van der Meulen EF; Hamming I; van Goor H; Navis G
Kidney Int; 2007 Mar; 71(5):417-24. PubMed ID: 17213874
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY
Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882
[TBL] [Abstract][Full Text] [Related]
5. Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.
Bos H; Laverman GD; Henning RH; Tiebosch AT; de Jong PE; de Zeeuw D; Navis G
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):106-12. PubMed ID: 12806593
[TBL] [Abstract][Full Text] [Related]
6. Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention.
Windt WA; Eijkelkamp WB; Henning RH; Kluppel AC; de Graeff PA; Hillege HL; Schäfer S; de Zeeuw D; van Dokkum RP
J Am Soc Nephrol; 2006 Nov; 17(11):3059-66. PubMed ID: 17005935
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
[TBL] [Abstract][Full Text] [Related]
8. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
9. Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.
Kikuchi Y; Imakiire T; Yamada M; Saigusa T; Hyodo T; Hyodo N; Suzuki S; Miura S
Nephrol Dial Transplant; 2005 Aug; 20(8):1573-81. PubMed ID: 15905195
[TBL] [Abstract][Full Text] [Related]
10. Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage.
Rook M; Lely AT; Kramer AB; van Goor H; Navis G
Nephrol Dial Transplant; 2005 Jan; 20(1):59-64. PubMed ID: 15572383
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats.
Hamming I; Navis G; Kocks MJ; van Goor H
J Pathol; 2006 May; 209(1):129-39. PubMed ID: 16532430
[TBL] [Abstract][Full Text] [Related]
12. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
13. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: a comparative study between ATRA and benazepril.
Hu P; Qin YH; Pei J; Lei FY; Hu B; Lu L
Exp Mol Pathol; 2010 Aug; 89(1):51-7. PubMed ID: 20493835
[TBL] [Abstract][Full Text] [Related]
15. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
Yu XQ; Nikolic-Paterson DJ; Mu W; Giachelli CM; Atkins RC; Johnson RJ; Lan HY
Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats.
Li C; Yang CW; Park CW; Ahn HJ; Kim WY; Yoon KH; Suh SH; Lim SW; Cha JH; Kim YS; Kim J; Chang YS; Bang BK
Kidney Int; 2003 Feb; 63(2):454-63. PubMed ID: 12631111
[TBL] [Abstract][Full Text] [Related]
17. Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective.
Eddy AA; Kim H; López-Guisa J; Oda T; Soloway PD
Kidney Int; 2000 Aug; 58(2):618-28. PubMed ID: 10916085
[TBL] [Abstract][Full Text] [Related]
18. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis.
Ophascharoensuk V; Giachelli CM; Gordon K; Hughes J; Pichler R; Brown P; Liaw L; Schmidt R; Shankland SJ; Alpers CE; Couser WG; Johnson RJ
Kidney Int; 1999 Aug; 56(2):571-80. PubMed ID: 10432396
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin II up-regulates osteopontin mRNA expression of RAW264.7 macrophages via p38MAPK signaling].
Lou N; Yu XQ; Zhu SL; Zheng XH; Dong XQ; Li XY
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1283-7. PubMed ID: 15387967
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W
J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
